Biocon and Biomm sign a license agreement for the Brazilian market for the diabetic medication semaglutide
Gourav kumar singh
April 17, 2024
Biocon and Biomm sign a license agreement for the Brazilian market for the diabetic medication semaglutide As per the deal, Biocon will be i...